Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial

•Urinary tract infections are very prevalent among postmenopausal women.•53% of women aged 55 reported a recurrence within a year in primary care.•Overuse of antibiotics increases antimicrobial resistance, threatening public health.•0.005% estriol gel lowers urinary infection rates in postmenopausal...

Ausführliche Beschreibung